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Abstract  
Ataxia Telangiectasia (AT) is caused by a mutation in the ataxia-telangiectasia-mutated 
(ATM) gene; the condition is associated with hyper-radiosensitivity, abnormal cell-cycle 
checkpoints, and genomic instability. A-T patients also show cerebellar ataxia, possibly 
due to reactive oxygen species (ROS) sensitivity in neural cells. The ATM protein is a 
key regulator of the DNA damage response. Recently, several AT-like disorders have 
been reported. The genes responsible for them are predicted to encode proteins that 
interact with ATM in the DNA-damage response. Ataxia with oculomotor apraxia types 
1, 2, and 3 (AOA1, 2, and 3) result in a neurodegenerative and cellular phenotype 
similar to AT; however, the basis of this phenotypic similarity is unclear. Here, we show 
that the cells of AOA3 patients display aberrant ATM-dependent phosphorylation and 
apoptosis following γ-irradiation. The ATM-dependent response to H2O2 treatment was 
abrogated in AOA3 cells. Furthermore, AOA3 cells had reduced ATM activity. Our 
results suggest that the attenuated ATM-related response is caused by an increase in 
endogenous ROS in AOA3 cells. Pretreatment of cells with pyocyanin, which induces 
endogenous ROS production, abolished the ATM-dependent response. Moreover, AOA3 
cells had decreased homologous recombination (HR) activity, and pyocyanin 
pretreatment reduced HR activity in HeLa cells. These results indicate that excess 
endogenous ROS represses the ATM-dependent cellular response and HR repair in 
AOA3 cells. Since the ATM-dependent cell-cycle checkpoint is an important block to 
carcinogenesis, such inactivation of ATM may lead to tumorigenesis as well as 
neurodegeneration.
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1. Introduction 
Double-strand breaks (DSBs) are generated in genomic DNA upon exposure 
to ionizing radiation (IR) or DNA-damaging agents such as bleomycin and 
neocarzinostatin. DSBs can also occur because of the collapse of stalled DNA 
replication forks. If left unrepaired, DSBs may induce genomic instability and promote 
apoptosis or tumorigenesis. When DSBs are recognized by cells, DNA repair factors 
access these sites of damage, are activated by protein kinases such as ATM, in the 
so-called DNA-damage response, and subsequently activate DNA repair mechanisms 
[1]. The study of radiation-hypersensitive genetic disorders has clarified the 
mechanisms of damage-induced cellular responses. One such disorder, Ataxia 
Telangiectasia (AT), is a rare autosomal recessive neurological condition associated 
with progressive cerebellar degeneration. AT is a multisystem syndrome characterized 
by immunodeficiency, predisposition to cancer, radiosensitivity, insulin-resistant 
diabetes, and premature aging [2]. In 1995, the mutated gene responsible for AT, 
ataxia-telangiectasia-mutated (ATM), was identified by positional cloning. ATM protein 
is activated in response to DSB damage and has a fundamental role in regulating 
cell-cycle checkpoints through the phosphorylation of DNA damage response (DDR) 
proteins including p53, checkpoint kinase 2 (Chk2), and Nijmegen breakage syndrome 
1 (NBS1) [1].  
Because many of the cellular and clinical features of AT and NBS overlap, the 
products of their causative genes are predicted to interact functionally. Bakkenist and 
Kastan [3] showed that radiation-induced DSBs cause intermolecular modification 
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within ATM dimers that leads to their activation through autophosphorylation at 
Ser-1981. This event triggers dimer dissociation and the free monomers subsequently 
phosphorylate several nuclear protein targets, which recruit DDR proteins [4]. Thus, we 
believe that ATM is a critical factor for the regulation of the DSB damage response. 
AT is a multisystem disease that involves the nervous, immune, endocrine, 
and reproductive systems [5,6]. Aicardi et al. described 14 patients with slowly 
progressive ataxia, choreoathetosis and oculomotor apraxia [7]. The patients had an 
unusual form of spinocerebellar degeneration similar to AT, but they were distinguished 
by the later age of onset and by the sole involvement of the nervous system. This 
condition, now known as ataxia–oculomotor apraxia (AOA), can be subdivided into 
three groups, AOA types 1, 2 [8,9], and 3 (AOA1, 2, and 3) [10]. Aprataxin, the 
defective factor in AOA1 [11,12], is involved in DNA single-strand break repair through 
resolving abortive DNA ligation intermediates [13,14]. The gene product defective in 
AOA2 cells, Senataxin, is also implicated in the DNA damage response, particularly in 
response to elevated ROS [15,16]. Recently, we demonstrated that the mitochondrial 
cytochrome b gene is mutated in AOA3 patients. This mutation leads to mitochondrial 
dysfunction, resulting in an increase in endogenous ROS and aberrant ROS-induced 
cellular responses, including p53-dependent apoptosis [14,17]. AT patients show 
symptoms of neural degeneration, such as cerebellar ataxia. Thus, disruption of the 
ATM-dependent ROS response in AT patients may lead to neural defects, such as 
ataxia-oculomotor apraxia and cerebellar atrophy. 
Several recent studies show that ATM plays a role in ROS-related cellular 
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responses. AT patients [18,19] and Atm knockout mice show high levels of oxidative 
damage [20, 21]. These data suggest that the impaired response to ROS in AT cells 
influences neuronal survival. Specifically, cerebellum cells exhibit low levels of 
NADPH [21], a major cofactor of antioxidant enzymes such as glutathione reductase 
and cytochrome P450 reductase. Together with superoxide dismutase and catalase, these 
enzymes are essential for maintenance of cellular redox balance [22]. Consistent with 
this finding, AT lymphoblasts reduce glutathione more slowly than do normal cells, in 
response to oxidative stress-induced glutathione depletion [23], possibly because of the 
low levels of NADPH. In fact, Cosentino et al. reported that ATM promotes 
p38-dependent phosphorylation of heat shock protein 27, contributing to the protection 
of cells against ROS accumulation through the glucose-6-phosphate dehydrogenase 
(G6PD)/NAPDH-dependent pathway [24]. Recently, Guo et al. showed that ROS 
directly induced ATM activation through the stabilization of the ATM dimers by the 
formation of disulfide bonds [25]. Therefore, neural degeneration in AOA3 might also 
be associated with defects in the ATM-related ROS response. 
Here, we show that AOA3 patient cells are defective in ATM-dependent 
phosphorylation and subsequent apoptosis. AOA3 cells also possess reduced ATM 
activity and the interaction between ATM and the MRN complex is disrupted. Our data 
suggest that the attenuation of the ATM-related response results from increasing 
endogenous ROS levels. We also discuss the relationship of ATM dysfunction with 
ataxia-like neural degeneration and tumorigenesis. 
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2. Materials and Methods 
2.1. Cell culture 
HeLa, U2OS, hTERT-immortalized human fibroblast (48BR), 
hTERT-immortalized AOA3 patient-derived fibroblast (PSF-hTERT), SV40-trasformed 
normal fibroblast (MRC5SV), and SV40-transformed AOA3 patient-derived fibroblast 
(PSF-SV) [26,10] cells were cultured in Dulbecco’s modified Eagle medium (Sigma) 
supplemented with 10% fetal bovine serum (FBS; Invitrogen) and antibiotics. Normal 
human (GM2184, C2ABR, and C3ABR; [10, 14]), AT patient-derived (CSA [27]), and 
AOA3 patient lymphoblastoid cells (ATL2ABR [10]) were cultured in Roswell Park 
Memorial Institute medium (Sigma) supplemented with 10% FBS and antibiotics. 
2.2. Irradiation  
Gammacell 40 Exactor (Nordion Inc., Kanata, Canada) was used for all 
irradiation experiments. The radioisotope source is 137Cs (132.2 TBq) and the dose rate 
is 0.9 Gy/min. 
2.3. Antibodies 
The following antibodies were used for western blot analysis or 
immunostaining: phospho-ATM (S1981) and γ-H2A histone family X (H2AX) mouse 
monoclonal antibodies (Millipore Co.); structural maintenance of chromosomes 1 
(SMC1) and phospho-SMC1 (S966) rabbit polyclonal antibodies (Bethyl Laboratories 
Inc.); phospho-p53 (S15) mouse monoclonal, phospho-Chk2 (T68) rabbit polyclonal, 
phospho-H2AX rabbit polyclonal and phospho-Chk1 (S317) rabbit polyclonal 
antibodies (Cell Signaling Technology); human meiotic recombination 11 (hMRE11) 
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rabbit polyclonal, hRAD50 rabbit polyclonal; and Nbs1 rabbit polyclonal antibodies 
(Novus Biologicals); p53 mouse monoclonal antibody (Santa Cruz Biotechnology); 
Rad51 mouse monoclonal antibodies (Abnova Co.); and  RPA34 (Ab-2) mouse 
monoclonal and H2B rabbit polyclonal antibody (Calbiochem).  
2.4. Western blot analysis 
Western blot analyses were carried out as described previously [26]. Target 
proteins were detected with the primary antibodies mentioned above and horseradish 
peroxidase (HRP)-conjugated anti-rabbit IgG or anti-mouse IgG antibodies (GE 
Healthcare). Proteins were visualized using the ECL plus chemiluminescence system 
(GE Healthcare).  
2.5. Immunofluorescence staining 
Immunofluorescence staining was carried out as described previously [26]. 
Alexa-488-conjugated anti-rabbit IgG or Alexa-594-conjugated anti-mouse IgG 
(Molecular Probes) were used to visualize the localization of the target proteins. 
2.6. ATM kinase assay 
The ATM kinase assay was carried out as described previously [28]. ATM was 
immunoprecipitated using an anti-ATM antibody (Calbiochem) from whole cell extracts. 
The phosphorylation of p53 (substrate) by immunoprecipitated ATM was estimated by 
western blot analysis using anti-phospho-p53 (S15) antibody (Cell Signaling). 
2.7. HR analysis 
Stable integrants for HR analysis with the DR-GFP construct in their genomic 
DNA were generated from normal donor (C3ABT and C12ABR) and AOA2 
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lymphoblastoid cell (ATL2ABR). HR analysis was performed as previously reported 
[29]. To measure the HR repair of I-SceI-generated DSBs, I-SceI expression vector 
(pCBASce, 50 µg) was introduced into 106 HeLa-DRGFP cells by electroporation 
(GenePulser; Bio-Rad). To determine the amount of HR repair, the percentage of 
GFP-positive cells was quantified 3 days post-electroporation by using the 
FACSCaliburTM flow cytometer (Becton Dickinson). 
2.8. Propidium iodide staining to detect apoptosis  
Lymphoblastoid cells from patients or normal donors were irradiated or left 
unirradiated. At the indicated times, cell were harvested, fixed using 70% ethanol, and 
then left at -20°C overnight. Fixed cells were treated with RNase (5 mg/ml) and stained 
with propidium iodide (PI; 50 µg/ml). The apoptotic fraction (sub G1) was quantified 
using a flow cytometer. 
 
3. Results 
3.1. AOA3 patient-derived cells are defective in DSB damage-induced ATM activation 
Cells derived from AOA3 patients cannot increase levels of p53 protein in 
response to γ-ray irradiation [10], suggesting that AOA3 patient cells possess a defect in 
ATM activation. Previously, we found that AOA3 lymphoblastoid cells (ATL2) and A-T 
cells (CSA) failed to upregulate p53 protein following irradiation, while normal cells 
(C3ABR) elevated p53 at 4 h post-irradiation (Fig. 1A). ATM-dependent 
phosphorylation of p53 at S15 and SMC1 at S966 was also defective in patient 
lymphoblastoid cells (Fig. 1C and Fig. S1A). As expected, autophosphorylation of ATM, 
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a hallmark of ATM activation, occurred in normal cells but not in AOA3 cells (Fig. 1A 
and Fig. S1A). NBS1, MRE11, and RAD50 are essential for DSB damage-induced 
ATM activation; expression of these factors in AOA3 cells was normal (Fig. 1A). We 
also examined irradiated AOA3 patient-derived fibroblasts (Fig. 1B). These cells 
(PSF-SV) exhibited neither ATM autophosphorylation nor ATM-dependent 
phosphorylation of SMC1 and histone H2AX (Fig. 1B). Although ATM/p53-dependent 
apoptosis can be induced in Epstein-Barr (EB) virus-transformed lymphoblastoid cells 
[30], the number of apoptotic cells was less than that observed in normal cells (Fig. 1D). 
Caspase 3 is normally activated as part of the apoptosis pathway; however, caspase 
3-dependent cleavage of PARP was not detected in AOA3 patient cells (ATL2ABR; Fig. 
1C). In the case of SV40-transformed fibroblasts, AOA3 (PSFSV) increased apoptosis 
after irradiation more than normal cells, similarly to AT fibroblasts (Fig. S2B). These 
data suggest that AOA3 cells cannot activate ATM and its associated pathways in 
response to DSB damage. 
 
3.2. AOA 3 patient-derived cells lack oxidative stress-dependent ATM activation 
Recently, Guo et al. reported that ATM is activated in vitro and in vivo 
following H2O2 treatment [25]. Other reports also suggest that oxidative stress induces 
the activation of ATM [31,32]. Figure 2A shows that H2O2 treatment at concentrations 
above 50 µM triggered autophosphorylation of ATM and ATM-dependent 
phosphorylation of SMC1 and Chk2 in normal lymphoblastoid cells (C2ABR), whereas 
AOA3 patient cells (ATL2ABR) showed decreases in SMC1 and Chk2 phosphorylation, 
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particularly at lower H2O2 concentrations (Fig. S1BC). In western blots, the delayed 
mobility of the NBS1 band indicated that it was phosphorylated. A delayed NBS1 band 
was not present in lysates of AOA3 cells treated with H2O2 (Fig. 2A). AOA3 patient 
cells showed basal autophosphorylation of ATM, but this did not increase with H2O2 
treatment. Phosphorylation of ATM was observed following H2O2 treatment in normal 
cells (MRC5SV), but the phosphorylation was remarkably less in patient cells (PSF-SV). 
EB virus transformation of lymphoblastoid cells induced ATM/p53-dependent apoptosis. 
However, ATM/p53-dependent apoptosis was not induced in transformed AOA 
lymphoblastoid cells. We also confirmed the apoptotic defect by examining PARP 
degradation. H2O2 treatment did not induce the cleavage of PARP in AOA3 cells (Fig. 
2C). Using PI staining, we confirmed repression of apoptosis in AOA3 cells (Fig. S2A). 
On the other hand, AOA3 fibroblasts as well as AT fibroblasts increased apoptosis 
following H2O2 treatment, compared with normal cells (Fig. S2C). These results suggest 
that AOA3 cells are also defective in oxidative stress-induced ATM activation. 
Oxidative stress-activation by the oxidizing agent diamide reportedly induces the 
homodimerization of ATM through the formation of disulfide bonds that subsequently 
activate ATM [25]. Diamide treatment induced autophosphorylation of ATM and 
subsequent phosphorylation of Chk2, p53, and SMC1 in normal cells (MRC5SV), but 
only slightly increased the phosphorylation of these factors in patient cells (Fig. 2D). 
Thus, ATM might form abnormal structures in AOA3 cells, leading to its inactivation. 
 
3.3. Endogenous ROS disrupts the interaction between ATM and the NBS1 complex 
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As shown in Fig. 1 and 2, ATM activity was abolished in AOA3 patient cells. 
Next, we verified the activity of ATM by using an in vitro kinase assay (Fig. 3A). 
Anti-ATM immunoprecipitates from irradiated cell extracts phosphorylated the p53 
substrate. H2O2 treatment also induced ATM kinase activity in vitro. However, the 
immunoprecipitates from AOA3 cells did not show ATM activity under any of the 
treatment conditions, consistent with the results shown in Fig. 1 and 2. Because the 
interaction of ATM and NBS1, and the subsequent recruitment of this complex to DSB 
damage sites are indispensable for sufficient activation of ATM [33], we examined this 
interaction in AOA3 patient-derived cells (Fig. 3B). In normal cells, the anti-ATM 
antibody coprecipitated NBS1 after irradiation. However, NBS1 could not be 
immunoprecipitated from irradiated AOA3 cells (ATL2ABR). As shown in Fig. S3A, 
phosphorylated ATM showed broad band in AOA3 cells (PSF), suggesting abnormal 
structure formation of ATM. This abnormal structure may disturb interaction between 
ATM and NBS1. Notably, oxidative stress did not stimulate the interaction between 
ATM and NBS1 in either normal or AOA3 cells (ATL2ABR; Fig. 3B). The absence of 
this interaction is in agreement with a previous report demonstrating that the 
MRE11/NBS1/RAD50 complex is dispensable for ROS-induced activation of ATM [25]. 
We also verified the interaction between ATM and NBS1 by immunofluorescence (Fig. 
3C and Fig. S3B). In more than 80% of hTERT-immortalized normal fibroblasts (48BR), 
there was a clear colocalization of phospho-ATM and NBS1 following irradiation (5 
Gy). Colocalization was not observed in more than 50% of patient fibroblasts (PSF-SV) 
treated under the same conditions. We speculate that abolishing the interaction between 
  12 
ATM and NBS1 leads to a deficiency in ATM activation in AOA3 cells. 
We recently reported that AOA3 cells show increased endogenous ROS levels, 
attributed to mitochondrial defects (Fig. S4) [17]. The increase in ROS levels may 
disrupt ATM activation and its associated responses. Pyocyanin, an electron receptor, 
disrupts the electron transport chain in mitochondria, leading to an increase in 
endogenous ROS. Pyocyanin treatment increased superoxide levels in normal cells (Fig. 
S6 and S7). γ-Ray irradiation (5 Gy) induced the phosphorylation of ATM and Chk2 in 
U2OS cells, but pyocyanin pretreatment suppressed the phosphorylation of these 
proteins (Fig. 3D). Therefore, we predict that the increase of endogenous ROS in AOA3 
cells prevents ATM activation in response to DNA damage. 
 
3.4. Endogenous ROS disrupts homologous recombination repair 
Kinases of the ATM family participate in DSB repairs via the 
non-homologous end-joining (NHEJ) and homologous recombination (HR) pathways. 
Among these kinases, DNA-dependent protein kinase catalytic subunit is an important 
regulator of NHEJ repair, and ataxia-telangiectasia and Rad3-related protein is reported 
to contribute to HR through the phosphorylation of Chk1 or other substrates [34]. ATM 
also participates in HR repair through the phosphorylation of H2AX protein and 
mediator of DNA damage checkpoint protein 1 (MDC1) [35,36]. Therefore, the increase 
in endogenous ROS may disrupt HR repair in AOA3 cells. We investigated whether 
AOA3 cells formed Rad51 foci, a marker for the initial step in the HR pathway, 
following irradiation (Fig. 4A and Fig S5). More than 20% of the normal cells (48BR) 
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possessed Rad51 foci 4 h after irradiation (5 Gy). However, Rad51 foci did not form in 
AOA3 cells (PSF) 4 h post-irradiation, suggesting a defect in HR in patient cells. To 
estimate HR activity, we used a DR-GFP reporter system [29]. HR repair of DSBs 
generated by I-SceI induces the cells to express GFP. HR activity can then be estimated 
by calculating the percentage of GFP-positive cells, quantified using a flow cytometer. 
To estimate HR activity in AOA3 cells, we generated normal donor and patient cell 
lines that possess the DR-GFP construct and then counted the number of GFP-positive 
cells, after introducing the I-SceI expression vector (Fig. 4B). Cultures of normal 
donor-derived cells (C3DR#1 and C12DR#2) contained approximately 5% 
GFP-positive cells, but this number decreased by more than half in patient cells 
(ATL2DR#10, ATL2DR#12). These results indicate that patient cells have reduced HR 
activity.  
As reported previously, AOA3 cells have increased endogenous ROS levels 
[17]. Figure 3D shows the increase in endogenous ROS by pyocyanin-repressed 
ATM-dependent phosphorylation. Thus, we investigated whether endogenous ROS also 
reduced HR activity (Fig. 4C). Approximately 10% of HeLa-DRGFP cells were 
GFP-positive after the introduction of I-SceI, but pyocyanin pretreatment decreased this 
to approximately 5%. However, NHEJ activity was not reduced by pyocyanin 
pretreatment (Fig. S5B). We speculate that the excess of endogenous ROS represses the 
HR repair pathway in AOA3 patient cells. 
 
4. Discussion 
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AOA3 and AT patients show similar neural degeneration phenotypes. 
AOA3-derived cells also have impaired induction of p53 in response to DSB damage 
[10]. Because the mutation associated with AOA is in cytochrome c, and the ATM gene 
in AOA patients is functional [17], it is unclear why AOA3 patients display 
p53-associated defects and an AT-like neural phenotype. Here, we demonstrate that 
AOA3 patient-derived cells are defective in ATM autophosphorylation and 
phosphorylation of ATM substrates following irradiation or H2O2 treatment (Fig. 1A, B 
and Fig. 2 A, B). ATM/p53-dependent apoptosis was also abolished in AOA3 cells (Fig. 
1C, D and Fig. 2C). ATM kinase activity is altered in AOA3 cells (Fig. 3A). 
Furthermore, our results suggest that ATM kinase is inactivated in AOA3 cells; that 
ATM cannot interact with NBS1 in irradiated AOA3 cells (Fig. 3BC); and that ATM is 
unable to dimerize and become active in response to diamide treatment (Fig. 3D). 
Moreover, pyocyanin-induced increases in endogenous ROS abrogated the 
phosphorylation of ATM and its substrates (Fig. 3D). These results suggest the 
following mechanism of ATM inactivation in AOA3 cells (Fig. 5). AOA3 cells increase 
endogenous ROS levels resulting from mitochondrial defects caused by the cytochrome 
c mutation, which could lead to abnormal homodimer formation of ATM through 
disulfide bonds. As a result, ATM cannot be activated by increased ROS and generation 
of DNA double-strand breaks (Fig. 5). 
We also showed that excess levels of endogenous ROS reduced DSB-induced activation 
of ATM in vivo. Specifically, an increase in endogenous ROS by pyocyanin treatment 
reduced DSB damage-induced activation of ATM in vivo (Fig. 3D). Few studies have 
  15 
directly addressed whether excess ROS influences ATM activation; however, the effect 
of H2O2 treatment on in vitro ATM activity has been reported [25]. In that study, the 
excess of H2O2 did not disrupt the interaction between ATM and the MRN complex, but 
it did appear to reduce MRN-dependent ATM activity in vitro. Excess H2O2 also 
reduced the binding of MRN with DNA. Therefore, excess ROS in AOA3 cells might 
also reduce ATM activation by inhibiting the MRN complex from binding to DSBs 
following irradiation. Although the report by Guo et al. showed that H2O2 treatment did 
not inhibit the interaction between ATM and the MRN complex [37], DSB 
damage-induced interaction was diminished in AOA3. Our previous work indicated that 
superoxide rather than H2O2 was elevated in AOA3 cells [17]. In this study, pyocyanin 
was found to increase endogenous superoxide, but H2O2 treatment did not (Fig. S6 and 
S7). Furthermore, pyocyanin treatment attenuated ATM activation in U2OS cells (Fig. 
3D), but H2O2 treatment did not. Therefore, we predict that the increase in endogenous 
superoxide interferes with ATM activation through disrupting the interaction between 
ATM and the MRN complex.  
We also speculate that the excess of endogenous ROS impairs HR repair. 
AOA3 cells reduced DSB damage-induced Rad51 foci formation and the DR-GFP 
assay showed that HR activity was reduced in AOA3 cells (Fig. 4A, B). In fact, the 
pyocyanin-induced increase in ROS also reduced HR activity according to the DR-GFP 
assay (Fig. 4C). The results of several studies suggest that ATM plays a role in the HR 
pathway [38-40]. The ATM-dependent phosphorylation of factors such as MDC1 and 
H2AX is important for the H2A/H2AX ubiquitination pathway and contributes to 
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recruitment of several HR factors [35,36]. The reduction of HR in AOA3 cells was 
attributed to inhibition of ATM activity by endogenous ROS in those studies. However, 
recent work shows that ATM is dispensable for HR repair in cells of various murine 
tissues [41], suggesting that inactivation of ATM by endogenous ROS is not critical for 
repression of HR repair. Guo et al. reported that excess ROS abolished the interaction 
between the MRN complex and double-strand DNA [37]. Because the MRN complex is 
critical for the initial step of HR repair, disrupting this interaction may inhibit the HR 
repair pathway in AOA3 cells. Alternatively, endogenous ROS may activate the 
stress-activated protein kinase (SAPK) pathway. Recently, the SAPK-dependent 
phosphorylation of Rad52 was shown to be indispensable for the regulation of HR in 
fission yeast [42]. Therefore, modulation of SAPK or other ROS-responsive enzymes is 
likely to affect the mammalian HR pathway. 
ATM plays a critical role in the cellular response to oxidative stress [24,25,43]. 
ATM-deficient human or mouse cells have increased levels of endogenous ROS and 
accumulate oxidative damage [18-21]. H2O2 treatment activates ATM both in vitro and 
in vivo [25], and ATM is indispensable for protection from ROS accumulation through 
the G6PD/NAPDH-dependent pathway [24]. ATM-deficient neural stem cells have 
reduced p38 mitogen-activated protein kinase (MAPK)-regulated proliferation. 
However, the antioxidant N-acetyl-L-cysteine or p38MAPK inhibitor can restore 
normal proliferation in these cells [44-46]. These findings indicate that the antioxidant 
function of ATM is essential for the proliferation of neural stem cells, suggesting that 
neural degeneration in AT patient results from a deficiency in the ATM anti-oxidative 
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response. As we showed here, ATM-related responses in AOA3 patient cells could be 
disturbed. This disturbance may influence ATM-related responses with oxidative stress 
in neural cells and lead to neurodegeneration phenotype in AOA3 cell. In order to 
clarify the detailed mechanisms of neurodegeneration and develop effective therapies 
for AOA3 or similar disorders, we must further evaluate the functional integrity of ATM 
in mitochondrial disorders such as AOA3 and other ataxia-associated diseases. 
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Figure legends 
Fig. 1. Oculomotor apraxia Type 3 (AOA3) cells have aberrant 
ataxia-telangiectasia-mutated (ATM)-dependent responses following irradiation. A–C: 
Normal (C3ABR), Ataxia Telangiectasia (AT; CSA), and AOA3 (ATL2ABR) 
lymphoblastoid cells, or normal (MRC5SV) and AOA3 (PSF-SV) fibroblasts were 
γ-ray-irradiated (5 Gy), harvested at the indicated times post-irradiation, and analyzed 
by western blot using the indicated antibodies. D: Normal (C3ABR), AT (CSA), and 
AOA3 (ATL2ABR) lymphoblastoid cells were γ-irradiated (5 Gy) and harvested at the 
indicated times post-irradiation. The cells were fixed in ethanol and stained with 
propidium iodide (PI). The percentage of apoptotic cells (sub G1) was quantified using 
a flow cytometer. 
 
Fig. 2. AOA3 cells are defective in the ATM-dependent response following H2O2 
treatment. A: Normal (C2ABR) and AOA3 (ATL2ABR) lymphoblastoid cells were 
treated with the indicated concentrations of H2O2 for 1 h. Harvested cells were analyzed 
by western blot using the indicated antibodies. B and C: Normal (C2ABR) and AOA3 
(ATL2ABR) lymphoblastoid cells, or normal (MRC5SV) and AOA3 (PSF-SV) 
fibroblasts were treated with 100 µM of H2O2 for 1 h. After washing out the H2O2, the 
cells were incubated for the indicated times. Harvested cells were then analyzed by 
western blot using the indicated antibodies. D: Normal (MRC5SV) and AOA3 
(PSF-SV) fibroblasts were treated with diamide (100 µM) for the indicated times. 
Harvested cells were analyzed by western blot using the indicated antibodies. 
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Fig. 3. AOA3 cells reduce ATM activity by disrupting the interaction between ATM and 
Nijmegen breakage syndrome (NBS1). A: Normal (C2ABR) or AOA3 (ATL2ABR) 
lymphoblastoid cells were γ-irradiated (10 Gy) or treated with H2O2, 100 µM. After 1 h, 
cells were harvested and a kinase activity assay was performed by generating 
immunocomplexes using an anti-ATM antibody. Phosphorylation was detected by 
western blot analysis using an anti-phospho-p53 antibody. The amount of substrate was 
confirmed using an anti-GST antibody. B: Extracts from normal (C2ABR) or AOA3 
(ATL2ABR) lymphoblastoid cells were immunoprecipitated with anti-ATM antibody, 
and the immunocomplexes were detected by western blot analysis using an anti-NBS1 
antibody. C: Normal (48BR) and AOA3 (PSF-SV) fibroblasts were γ-irradiated (5 Gy). 
After 30 min., the cells were fixed and immunostaining was performed using 
anti-phospho-ATM and anti-NBS1 antibodies. DAPI staining (blue) was used to 
counterstain the nuclei. (D) U2OS cells were pretreated with pyocyanin (50 µM) for 24 
h. The cells were γ-irradiated (5 Gy) and harvested at the indicated times 
post-irradiation. Cell lysates were then analyzed by western blot using indicated 
antibodies. 
 
Fig. 4. AOA3 cells reduce homologous recombination repair activity.  
A: Normal (48BR) and AOA3 (PSF-hTERT) fibroblasts were γ-irradiated (5 Gy). After 
4 h, the cells were fixed and immunostaining was performed using an anti-Rad51 
antibody. Rad51 foci-positive cells were counted under a fluorescence microscope. B: 
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AOA3 lymphoblastoid cells with reduced HR activity. I-SceI expression plasmids were 
electroporated into normal or AOA3 lymphoblastoid cells, carrying DRGFP construct in 
their genome. After 3 d, GFP-positive cells, which have an activated HR pathway, were 
analyzed using a flow cytometer. C: HeLa-DRGFP cells were pretreated with pyocyanin 
(50 µM) for 24 h. I-SceI expression plasmids were introduced into cells carrying the 
DR-GFP construct in their genome. After 3 d, GFP-positive cells were analyzed using a 
flow cytometer. 
 
Fig. 5. Excess endogenous ROS inactivate ATM in AOA3 cells. In normal cells, 
increases in exogenous or endogenous ROS trigger dimerization of ATM as active form 
through a disulfide bond. However, in the case of AOA3 cells, excess endogenous ROS 
make ATM form abnormal dimers through many disulfide bonds. As a result, ATM 
cannot be activated by ROS and DNA damage. Such inactivation of ATM could lead to 
neurodegeneration, gene mutation and genomic instability. 
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